News

08.07.2019

"Patient centricity means communicating on eye level"

The university hospital of Basel not only wants to use innovation, but also drive innovation. For this reason, the hospital established an Innovation Lab recently and launched an internal support program to help put innovation projects into practice. Driving forces behind this initiative are Jens Eckstein and Marc Strasser. DayOne asked Jens Eckstein about this push for innovation.

mehr >
19.07.2019

EuroAirport top the charts in terms of efficiency

EuroAirport top the charts in terms of efficiency

EuroAirport Basel-Mulhouse-Freiburg is the most efficient airport of its size in Europe. It has now been presented with the Top Efficiency Excellence Award by the research network ATRS.

mehr >
18.07.2019

Novartis enjoys success

Novartis enjoys success

Basel pharmaceuticals giant Novartis has enjoyed a successful second quarter and has now increased its full year guidance. Contributors to the growth are two innovative new medicines.

mehr >
11.06.2019

"I am amazed by the level of innovation in the Jura"

The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third in the Jura. It will be located on the Innodel campus in the municipality of Courroux, between Delémont and Courrendlin. Work is ongoing at the Jura site, which is set to officially open on 25 October.

mehr >
12.07.2019

Basel home to two of the most valuable companies

Basel home to two of the most valuable companies

The two Basel-based pharma giants Roche and Novartis rank among the 100 most valuable listed companies in the world, according to a report from EY. Nestlé, the Swiss food company, also made the list.

mehr >
11.07.2019

Jura promotes brownfield land

Jura promotes brownfield land

The Canton of Jura boasts 51 hectares of brownfield land ripe for development. Around half of the sites are in commercial zones. If developed, there would be space for some 2,100 workplaces and inhabitants.

mehr >
06.05.2019

“Here at Bell, we combine handcraft and automation”

“Here at Bell, we combine handcraft and automation”

Over the space of 150 years, a butcher’s in Basel has grown into an international food company, with the Bell Food Group now employing more than 12,000 people in 15 countries. Markus Ettlin, Head of Industry 4.0/Automation at the Bell Food Group, provides an update on the company’s current Industry 4.0 projects, the limits of automation, and innovations in the food sector.

mehr >
09.07.2019

New partners join rock laboratory

The Mont Terri rock laboratory in Saint-Ursanne is one of the leading organizations conducting research into clay formation. Its partners stem from across the world, but with two new institutions the field of research is now set to grow.

mehr >
04.07.2019

DayOne Lab: An inspiring place for digital health innovators

DayOne Lab: An inspiring place for digital health innovators

The DayOne Lab at the Technologiepark Basel provides a new and unique place for collaboration, creation and innovation: The lab is dedicated to startups, entrepreneurs and intrapreneurs and innovators in the realm of digital health who are interested in interacting with the residents at Technologiepark and keen to play an active role in strengthening the ecosystem in the Basel region.

mehr >
02.04.2019

“The Basel region is very advanced in healthcare innovation”

“The Basel region is very advanced in healthcare innovation”

A new master’s degree at the FHNW University of Applied Sciences and Arts Northwestern Switzerland aims to prepare the next generation of professionals in the life sciences industries: Students in “Medical Informatics” are trained to apply the latest technologies during projects for the medical and pharmaceutical industries. Professor Enkelejda Miho from the Institute for Medical and Analytical Technologies at FHNW is confident that the combination of life sciences, informatics and business brings forward a desired new profile of professionals.

mehr >
04.07.2019

Basel surgeons celebrate world first clinical surgery

Basel surgeons celebrate world first clinical surgery

The world’s first upper jaw corrective surgery using robot-guided cold laser ablation has been carried out at the University Hospital Basel. Bones were cut without any contact.

mehr >
03.07.2019

Lonza extends services with new factory

Lonza extends services with new factory

Basel-based chemicals and pharmaceuticals company Lonza acquires facility for sterile drug manufacturing from Novartis. With the new production facility in Stein AG Lonza will extend its service offering, as well as taking on the existing employees and providing investment in Basel.

mehr >
28.03.2019

33 recently arrived companies create hundreds of jobs

Basel and the Rhine - attractive for companies (img: Basel Tourismus)

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year – were persuaded to move to the Basel economic region. 16 companies arrived from Europe, nine of which came from Germany. BaselArea.swiss also supported six Swiss companies in the search for a suitable business location in the Basel region. Of the newly arrived companies, 19 operate in the life sciences and chemicals sectors.

mehr >
02.07.2019

Basel wird zum Innovationszentrum für Notenbanken

The Bank for International Settlements is to set up an Innovation Hub to foster collaboration on innovative financial technologies between central banks. One of the first three hub centers will be in Basel.

mehr >
01.07.2019

Switzerland can withstand major shocks

Switzerland can withstand major shocks

Switzerland is the best-prepared country in the world for climate change and other shocks, KPMG finds. This is the second year in a row that Switzerland has come in first place in KPMG’s Change Readiness Index.

mehr >
05.03.2019

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from Advancience are examples of how far conviction can get you.

mehr >
28.06.2019

On the verge of being born: Next generation clinical trials

Audience at the DayOne Expert event - Next Generation Clinical Trials

Tomasz Sablinski, Founder and CEO of Transparency Life Sciences raised the crunch question of the evening: Which industry is lagging behind the most in terms of digitization? Right, it is the healthcare industry! But who would have expected the usual lamentation of why this is the case; blaming regulatory constraints, scarce innovation culture, or unachievable technology barriers proved wrong. The appetite for change and finding new ways of doing things was too strong among Basel’s Healthcare innovators at the DayOne Expert Session on “Next Generation Digital Trials”.

mehr >
27.06.2019

The new Process Technology Center at FHNW impresses industry and students

The new Process Technology Center at FHNW impresses industry and students

140 visitors paid a visit to the new Process Technology Center (PTC) at the FHNW Campus Muttenz where the School invested 30 million Swiss francs in equipment and installations. The opening of the PTC, on June 20th 2019, was an impressive demonstration of the School of Life Sciences located in the fascinating new Kubuk in Muttenz. The University of Applied Sciences (FHNW) and within this organisation, the School of Life Sciences, is becoming an increasingly vital part in the economic system of Basel.

mehr >
05.02.2019

“We are a small company with a big portfolio”

“We are a small company with a big portfolio”

After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s biggest biotech, the company and its late-stage pipeline were acquired by Johnson&Johnson in 2017. With Actelion’s discovery- and early-stage R&D assets, the couple formed Idorsia, with the vision to build one of Europe’s leading biopharmaceutical companies

mehr >
27.06.2019

Basel-Landschaft parliament approves 11 million for Innovation Park

Basel-Landschaft parliament approves 11 million for Innovation Park

The Basel-Landschaft cantonal parliament has approved contributions totaling 11.3 million Swiss francs for the Switzerland Innovation Park Basel Area. This investment will be used to strengthen the life science cluster in Northwest Switzerland.

mehr >
25.06.2019

Northwestern Switzerland is one of the most innovative regions in Europe

Northwestern Switzerland is one of the most innovative regions in Europe

Switzerland remains the leading European country for innovation performance. This is a finding of the Innovation Scoreboard compiled by the European Union (EU). Moreover, Northwest Switzerland with Basel was named the seventh most innovative region in Europe. Northwestern Switzerland is leading the field in the area of "public-private co-publications per million population" and stands out in lifelong learning. The area is also above both the Swiss and the EU average in terms of patent and trademark applications.

mehr >
08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
25.06.2019

Grand succès pour l’édition 2019 du salon genevois EPHJ

Grand succès pour l’édition 2019 du salon genevois EPHJ

Excellent bilan pour la 18ème édition du Salon EPHJ avec des éléments très positifs tant au niveau de la fréquentation en légère hausse de 4 pour cent par rapport à l’année précédente que de la satisfaction des 820 entreprises exposantes.

mehr >
25.06.2019

BioVersys receives grant

BioVersys has received a grant of 6.92 million Euro for its new compound against tuberculosis. In future, the candidate molecules from the TRIC-TB project could boost the efficacy of an established drug.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >
24.06.2019

Swiss TPH breaks ground on new headquarters

Swiss TPH breaks ground on new headquarters

The Swiss Tropical and Public Health institute (Swiss TPH) has broken ground on the new building for its headquarters in Allschwil. Set for completion by the end of 2021, the new building will offer nearly 900 workplaces, laboratory spaces as well as teaching facilities.

mehr >
21.06.2019

Axovant agrees manufacturing partnership

Axovant agrees manufacturing partnership

The Basel-based pharma group Axovant has agreed a manufacturing partnership with Yposkesi. Axovant will benefit from expanded production capacities to manufacture gene therapies.

mehr >
23.11.2018

Expats like Basel best

Expats like Basel best

Expats find Basel to be the best city in Switzerland, according to a study published by InterNations. Six Swiss cities were analyzed as part of its latest Expat City Ranking.

mehr >
19.06.2019

Polyphor starts breast cancer trial

Polyphor starts breast cancer trial

Allschwil-based pharmaceutical company Polyphor has enrolled the first patient in its pivotal Phase III study. It is evaluating the efficacy of antagonist balixafortide in patients with metastatic breast cancer

mehr >
19.06.2019

Immigrants praise quality of life

Immigrants praise quality of life

Those who move to Basel generally assign a higher score to the city for quality of living and life than to their old home. This is a finding from a survey of immigrants conducted by the canton. Respondents praised aspects including public transport and the city’s cultural offering.

mehr >
14.11.2018

Roivant raised USD 200 million, now valued at USD 7 billion

Roivant raised USD 200 million, now valued at USD 7 billion

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion.

mehr >
18.06.2019

Findings from Basel enable improved breast cancer treatment

Findings from Basel enable improved breast cancer treatment

Basel – A recently published study investigated in greater detail the formation of metastases in the indication of breast cancer. The findings will impact treatment techniques. University Hospital Basel was also involved in the study.

mehr >
13.06.2019

Basel researchers facilitate new libraries for drug discovery

Basel researchers facilitate new libraries for drug discovery

Researchers at the University of Basel have developed an approach for building up new substance libraries. These will support the discovery of new medicines.

mehr >
05.11.2018

Three entrepreneurs, three visions of Industry 4.0

Dominik Trost (holo|one), Philippe Kapfer (NextDay.Vision), Roy Chikballapur (MachIQ)

BaselArea.swiss invited startups and Industry 4.0 projects to participate in the first Industry 4.0 Challenge. A jury from the industry chose three finalists: Philippe Kapfer with NextDay.Vision, Roy Chikballapur with MachIQ and Dominik Trost with holo|one. Learn more about their contributions and visions in the interview. You can meet the entrepreneurs at the Salon Industries du Futur Mulhouse on 20 and 21 November 2018.

mehr >
11.06.2019

Project uptown Basel taking shape

Project uptown Basel taking shape

A competence center for Industry 4.0 is being created on the former site of ABB. Private investors have contributed around half a million Swiss francs to the project. The foundation stone has now been officially laid.

mehr >
11.06.2019

Roivant Sciences: On a mission to combine the best of pharma and technology

Roivant Sciences: On a mission to combine the best of pharma and technology

Pharma companies around the world are facing the same challenge: The blockbuster drugs are already developed and commercialized. What does meaningful innovation that enhances the return on investment look like for forward-thinking experts in the industry? The Roivant Sciences Third Annual Symposium at Messe Basel explored “Innovation in pharma business models”.

mehr >
27.09.2018

"I Was Always One of Few Women in the Industry"

SOLO Swiss in Porrentruy in the canton of Jura has been making industrial furnaces for heat-treating metals since 1924. The family company with a global presence is developing against the backdrop of Industry 4.0 and is struggling to find the qualified workforce which is indispensable for what it does amid the effects of the strong franc and what are sometimes restrictive administrative regulations. Interview with Anne-Sophie Spérison, President and CEO.

mehr >
11.06.2019

Switzerland Innovation Park Basel Area offre des ateliers et séminaires pour innover

Switzerland Innovation Park Basel Area offre des ateliers et séminaires pour innover

Venez innover avec nous ! Tel est le slogan pour les ateliers et séminaires qui seront organisés dans le Switzerland Innovation Park Basel Area du Jura pour les entreprises jurassiennes. Un programme alléchant qui traitera autant de sujets de diversification que de thématiques telles que l’intelligence artificielle ou le design thinking. A coup sûr, ce sont des sujets qui vous intéresseront.

mehr >
06.06.2019

BaseLaunch is a world-leading accelerator

BaseLaunch is a world-leading accelerator

Healthcare accelerators recently came under the spotlight of technology platform Technorely. Its list of eight of the leading accelerators features BaselArea.swiss-operated BaseLaunch as one of only two outside North America.

mehr >
04.09.2018

“Our business is the most beautiful business in the world”

“Our business is the most beautiful business in the world”

Giacomo di Nepi has a successful history: A high level executive in big corporations, he transitioned towards biotech, currently as CEO of Polyphor, which, in May 2018, he led to the IPO. We spoke to Giacomo about serving patients, the timing for an IPO and the people needed in a biotech.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)